Issue 2/2014
Content (13 Articles)
Circulating MicroRNAs in Drug Safety Assessment for Hepatic and Cardiovascular Toxicity: The Latest Biomarker Frontier?
Mitsuhiko Osaki, Nobuyoshi Kosaka, Futoshi Okada, Takahiro Ochiya
Comprehensive Profiling of EGFR/HER Receptors for Personalized Treatment of Gynecologic Cancers
Henry D. Reyes, Kristina W. Thiel, Matthew J. Carlson, Xiangbing Meng, Shujie Yang, Jean-Marie Stephan, Kimberly K. Leslie
Preclinical Imaging: an Essential Ally in Modern Biosciences
Lídia Cunha, Ildiko Horvath, Sara Ferreira, Joana Lemos, Pedro Costa, Domingos Vieira, Dániel S. Veres, Krisztián Szigeti, Teresa Summavielle, Domokos Máthé, Luís F. Metello
Circulating Melanoma Cells in the Diagnosis and Monitoring of Melanoma: An Appraisal of Clinical Potential
Brigid S. Mumford, Gavin P. Robertson
Sensitive Solid-Phase Detection of Donor-Specific Antibodies as an Aid Highly Relevant to Improving Allograft Outcomes
Gerald Schlaf, Beatrix Pollok-Kopp, Wolfgang W. Altermann
A Rationalized Approach to the Treatment of Patients Infected with Hepatitis B
Natravis R. Cox, Keyur Patel, Hans L. Tillmann
Biomarker Modelling of Early Molecular Changes in Alzheimer’s Disease
Ross W. Paterson, Jamie Toombs, Catherine F. Slattery, Jonathan M. Schott, Henrik Zetterberg
The Effect of Genetic Polymorphisms of Cytochrome P450 CYP2C9, CYP2C19, and CYP2D6 on Drug-Resistant Epilepsy in Turkish Children
Mehmet Seven, Bahadir Batar, Selin Unal, Gozde Yesil, Adnan Yuksel, Mehmet Guven
MicroRNA-499 rs3746444 Polymorphism and Autoimmune Diseases Risk: A Meta-Analysis
Lechun Lu, Ying Tu, Lingxin Liu, Jue Qi, Li He
Association of E-Selectin Gene Polymorphism and Serum PAPP-A with Carotid Atherosclerosis in End-Stage Renal Disease
Marianne Samir M. Issac, Alaa Afif, Nadida A. Gohar, Nahla A. Fawzy Fayek, Bahaa Zayed, Heba Sedrak, Lamiaa Adel Salah El Din
Association Between Catechol-O-Methyltransferase (COMT) Gene Polymorphisms, Parkinson’s Disease, and Levodopa Efficacy
Bowen Yin, Yongqian Chen, Limei Zhang